Eagle’s Eye View: Your Weekly CV Update From ACC.org (Week of Sept. 27)

This week's View focuses on the effect of neprilysin inhibition on BP in patients with HFpEF and resistant hypertension, three- vs. two-drug therapy for patients with newly diagnosed pulmonary artery hypertension, and early invasive angiography in acute HF.

Clinical Topics: Anticoagulation Management, Arrhythmias and Clinical EP, Cardiac Surgery, Cardiovascular Care Team, Geriatric Cardiology, Heart Failure and Cardiomyopathies, Invasive Cardiovascular Angiography and Intervention, Noninvasive Imaging, Prevention, Aortic Surgery, Cardiac Surgery and Arrhythmias, Cardiac Surgery and Heart Failure, Cardiac Surgery and SIHD, Statins, Acute Heart Failure, Heart Failure and Cardiac Biomarkers, Interventions and Imaging, Angiography, Nuclear Imaging, Hypertension, Pulmonary Hypertension and Venous Thromboembolism, Stable Ischemic Heart Disease

Keywords: EaglesEyeView, Angina Pectoris, Coronary Angiography, Coronary Artery Bypass, Emergency Service, Hospital, Geriatrics, Heart Failure, Myocardial Infarction, Myocardial Ischemia, Myocardial Revascularization, Patient Readmission, Percutaneous Coronary Intervention, Secondary Prevention, Troponin, Antihypertensive Agents, Blood Pressure, Calcium Channel Blockers, Creatinine, Diabetes Mellitus, Diuretics, Glomerular Filtration Rate, Heart Failure, Hyperkalemia, Hypertension, Hypotension, Myocardial Infarction, Natriuretic Peptide, Brain, Neprilysin, Secondary Prevention, Stroke, Stroke Volume, Valsartan, Acetamides, Arterial Pressure, Atrial Pressure, Cardiac Catheterization, Diarrhea, Headache, Heart Failure, Natriuretic Peptide, Brain, Nausea, Peptide Fragments, Primary Prevention, Pulmonary Arterial Hypertension, Pyrazines, Pyrimidines, Sulfonamides, Tadalafil, Vascular Resistance

< Back to Listings